Mark K. Slifka

Dr. Mark K. Slifka

Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2007 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
IAIan J. Amanna
Ian J. Amanna
NCNichole E. Carlson
Nichole E. Carlson
Mark K. SlifkaMark K. Slifka
Mark K. Slifka
Maintenance of long-term antibody responses is critical for protective immunity against many pathogens. However, the duration of humoral immunity and the role played by memory B cells remain poorly defined.

1 August 2001 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
Mark K. SlifkaMark K. Slifka
Mark K. Slifka
JWJ. Lindsay Whitton
J. Lindsay Whitton

15 June 2010 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
IAIan J. Amanna
Ian J. Amanna
Mark K. SlifkaMark K. Slifka
Mark K. Slifka


4 June 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BFBailey E. Freeman
Bailey E. Freeman
EHErika Hammarlund
Erika Hammarlund
HRHans-Peter Raué
Hans-Peter Raué
Mark K. SlifkaMark K. Slifka
Mark K. Slifka
Virus-specific CD8+T cells develop the ability to function in an “innate” capacity by responding to a remarkable array of cytokines in a TCR-independent manner. Although several cytokines such as IL-12 and IL-18 have been identified as key regulators of CD8+T-cell activation, the role of other cytokines and the ways in which they interact with each other remain unclear. Here, we have used an unbiased, systematic approach to examine the effects of 1,849 cytokine combinations on virus-specific CD8+T-cell activation. This study identifies several unexpected cytokine combinations that synergize to induce antigen-independent IFNγ production and CD69 up-regulation by CD8+T cells in addition to cytokines that exhibit differential regulatory functions, with the ability to either enhance or inhibit T-cell IFNγ production, depending on which cytokine partner is present. These findings underscore the complexity of cytokine interactions while also providing insight into the multifaceted regulatory network controlling virus-specific CD8+T-cell functions.

24 November 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
EHErika Hammarlund
Erika Hammarlund
ATArchana Thomas
Archana Thomas
IAIan J. Amanna
Ian J. Amanna
LHLindsay A. Holden
Lindsay A. Holden
OSOv D. Slayden
Ov D. Slayden
Mark K. SlifkaMark K. Slifka
Mark K. Slifka
Pre-existing serum antibodies play an important role in vaccine-mediated protection against infection but the underlying mechanisms of immune memory are unclear. Clinical studies indicate that antigen-specific antibody responses can be maintained for many years, leading to theories that reactivation/differentiation of memory B cells into plasma cells is required to sustain long-term antibody production. Here, we present a decade-long study in which we demonstrate site-specific survival of bone marrow-derived plasma cells and durable antibody responses to multiple virus and vaccine antigens in rhesus macaques for years after sustained memory B cell depletion. Moreover, BrdU+cells with plasma cell morphology can be detected for 10 years after vaccination/BrdU administration, indicating that plasma cells may persist for a prolonged period of time in the absence of cell division. On the basis of these results, long-lived plasma cells represent a key cell population responsible for long-term antibody production and serological memory.